We have been archiving all OBR daily news stories since March 2008. Use the box below to search our archives for specific articles and content. Please note: we do not "host" news articles on our website. When a media source removes an article from their website the link becomes inactive, and you will only be able to see the date, title, first sentence and media source that published the article.
(Forbes) July 26, 2017 - Disincentives plague the U.S. health care system, driving costs higher and the quality of care lower.
(GenEngNews) July 27, 2017 - Scientists in the U.S. have created genetically engineered mesenchymal stem cells (MSCs) that can recognize and target "stiff" metastatic tumor tissue and deliver cancer-killing drugs directly to the tumor site.
(STAT Plus) July 26, 2017 - I was saddened to hear that you received a diagnosis of glioblastoma. I also live with this particularly aggressive type of brain cancer.
(TFCI) July 26, 2017 - Scientists have uncovered how cells are kept in the right place as the body develops, which may shed light on what causes invasive cancer cells to migrate.
(STAT Plus) July 26, 2017 - After several years in which drug makers have been pressured to release clinical trial data, a new analysis finds many companies are still doing an incomplete or inconsistent job of being transparent.
(New York Times/Well blog) July 27, 2017 - Many people associate palliative care with hospice care, but medical professionals are offering it to children and adolescents living with cancer as well as to those dying from it.
(Reuters) July 26, 2017 - Dynavax Technologies Corp's experimental hepatitis B vaccine is effective, but there were more deaths and serious heart problems in patients given the vaccine than in those given a rival product, according to a preliminary Food and Drug Administration report published on Wednesday.
(Bloomberg) July 27, 2017 - AstraZeneca Plc shares plunged by the most ever after the U.K. drugmaker suffered a blow to its next-generation cancer therapy in a major setback to Chief Executive Officer Pascal Soriot’s ambitions.
(Yahoo! Finance) July 27, 2017 - Soligenix, Inc., a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced today that patient enrollment has been opened for its Phase 3, multinational, randomized, double-blind, placebo-controlled study evaluating SGX942 (dusquetide) as a treatment for severe oral mucositis in patients with head and neck cancer receiving chemoradiation therapy (CRT).
(Boston Globe) July 27, 2017 - Senate Republicans failed in another attempt to overturn the Affordable Care Act Wednesday, forcing them to next consider modestly scaling back the law rather than the outright repeal they have long promised.